Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer - Centre de recherche des Cordeliers Access content directly
Journal Articles Cell Death and Disease Year : 2023

Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer

Julia Källberg
Alexandra Harrison
  • Function : Author
Valerie March
  • Function : Author
Santa Bērziņa
  • Function : Author
Ivan Nemazanyy
Oliver Kepp
Guido Kroemer
Sophie Mouillet-Richard
Pierre Laurent-Puig
Wenjin Xiao

Abstract

The major underlying cause for the high mortality rate in colorectal cancer (CRC) relies on its drug resistance, to which intratumor heterogeneity (ITH) contributes substantially. CRC tumors have been reported to comprise heterogeneous populations of cancer cells that can be grouped into 4 consensus molecular subtypes (CMS). However, the impact of inter-cellular interaction between these cellular states on the emergence of drug resistance and CRC progression remains elusive. Here, we explored the interaction between cell lines belonging to the CMS1 (HCT116 and LoVo) and the CMS4 (SW620 and MDST8) in a 3D coculture model, mimicking the ITH of CRC. The spatial distribution of each cell population showed that CMS1 cells had a preference to grow in the center of cocultured spheroids, while CMS4 cells localized at the periphery, in line with observations in tumors from CRC patients. Cocultures of CMS1 and CMS4 cells did not alter cell growth, but significantly sustained the survival of both CMS1 and CMS4 cells in response to the front-line chemotherapeutic agent 5-fluorouracil (5-FU). Mechanistically, the secretome of CMS1 cells exhibited a remarkable protective effect for CMS4 cells against 5-FU treatment, while promoting cellular invasion. Secreted metabolites may be responsible for these effects, as demonstrated by the existence of 5-FU induced metabolomic shifts, as well as by the experimental transfer of the metabolome between CMS1 and CMS4 cells. Overall, our results suggest that the interplay between CMS1 and CMS4 cells stimulates CRC progression and reduces the efficacy of chemotherapy.
Fichier principal
Vignette du fichier
s41419-023-05806-z.pdf (3.44 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-04301309 , version 1 (22-11-2023)

Identifiers

Cite

Julia Källberg, Alexandra Harrison, Valerie March, Santa Bērziņa, Ivan Nemazanyy, et al.. Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer. Cell Death and Disease, 2023, 14, ⟨10.1038/s41419-023-05806-z⟩. ⟨hal-04301309⟩
9 View
5 Download

Altmetric

Share

Gmail Facebook X LinkedIn More